Trial of analgesia with lidocaine or extended-release oxycodone for neuropathic pain treatment in multiple sclerosis (TALENT-MS)

Trial Profile

Trial of analgesia with lidocaine or extended-release oxycodone for neuropathic pain treatment in multiple sclerosis (TALENT-MS)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 22 Jul 2015

At a glance

  • Drugs Lidocaine (Primary) ; Oxycodone (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Acronyms TALENT-MS
  • Most Recent Events

    • 17 Aug 2011 Trial phase change from II to IV as reported by ClinicalTrials.gov.
    • 17 Aug 2011 Planned end date 1 Aug 2011 added as reported by ClinicalTrials.gov.
    • 13 Apr 2010 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top